Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10829	Companies
234913	Keywords
163767	Articles
125737	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 11/20/2025 at 15:00, 8 months 22 days ago

In Support of Possible Expedited Approval Pathway for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID), Jaguar Health Submits Amended Protocol to FDA for Ongoing Placebo-Controlled Clinical Trial
Jaguar Health submits amended protocol to FDA for crofelemer in pediatric MVID patients to potentially extend lives and reduce parenteral support by up to 37%

FDA Crofelemer Jaguar Health Pediatric Patients MVID
BRIEF

published on 11/17/2025 at 14:05, 8 months 25 days ago

Jaguar Health annonce une légère hausse de son chiffre d'affaires au troisième trimestre 2025.

Crofelemer Jaguar Health Résultats Financiers Du Troisième Trimestre Revenu Net Traitement MVID
BRIEF

published on 11/17/2025 at 14:05, 8 months 25 days ago

Jaguar Health Reports Modest Revenue Increase in Q3 2025 Financials

Crofelemer Jaguar Health Net Revenue Q3 Financials MVID Treatment
PRESS RELEASE

published on 11/17/2025 at 14:00, 8 months 25 days ago

Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue
Jaguar Health, Inc. reports proof-of-concept trial shows crofelemer potential for MVID patients, financial results revealed, FDA meeting outcome, and upcoming investor webcast

Financial Results Crofelemer Investor Webcast Jaguar Health Inc. MVID
BRIEF

published on 11/14/2025 at 15:05, 8 months 28 days ago

Jaguar Health organisera une webdiffusion pour les investisseurs le 17 novembre 2025.

Rapport Financier Jaguar Health Magdalena Biosciences Webinaire Pour Les Investisseurs Médicaments Gastro-intestinaux
BRIEF

published on 11/14/2025 at 15:05, 8 months 28 days ago

Jaguar Health to Host Investor Webcast on November 17, 2025

Financial Report Investor Webcast Jaguar Health Magdalena Biosciences Gastrointestinal Medicines
PRESS RELEASE

published on 11/14/2025 at 15:00, 8 months 28 days ago

Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates
Jaguar Health, Inc. (NASDAQ:JAGX) to file Earnings Report on Form 10-Q for quarter ended September 30, 2025. Investor webcast on November 17, 2025 at 8:30 a.m. Eastern to review financials and provide corporate updates

Earnings Report Investor Webcast Jaguar Health Form 10-Q NASDAQ:JAGX
BRIEF

published on 11/13/2025 at 15:05, 8 months 29 days ago

Jaguar Health met en avant des résultats d'étude prometteurs concernant le crofélémère dans l'insuffisance intestinale pédiatrique

Crofelemer Essai Clinique Insuffisance Intestinale Chez L'enfant Maladie À Inclusions Microvillositaires Soutien Parentéral
BRIEF

published on 11/13/2025 at 15:05, 8 months 29 days ago

Jaguar Health Highlights Promising Study Results for Crofelemer in Pediatric Intestinal Failure

Crofelemer Microvillus Inclusion Disease Clinical Trial Pediatric Intestinal Failure Parenteral Support
PRESS RELEASE

published on 11/13/2025 at 15:00, 8 months 29 days ago

Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at NASPGHAN Annual Meeting
Crofelemer shows promising results in reducing total parenteral support for MVID patients, presented at NASPGHAN. Jaguar Health's investigation explores breakthrough benefits for pediatric patients with intestinal failure

Crofelemer Jaguar Health MVID Intestinal Failure NASPGHAN

Accesswire

Published on 08/13/2026 at 00:30, 5 hours 44 minutes ago

Aton Closes CAD$4 Million Private Placement
Published on 08/12/2026 at 23:30, 6 hours 44 minutes ago

CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/12/2026 at 23:30, 6 hours 44 minutes ago

Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle
Published on 08/12/2026 at 23:20, 6 hours 54 minutes ago

RJK Explorations Ltd. Announces Upsize of Previously Announced Private Placement
Published on 08/12/2026 at 23:05, 7 hours 9 minutes ago

Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend

View all ACCESSWIRE

EQS Group

Published on 08/13/2026 at 06:00, 14 minutes ago

Schlatter posts a profit in the first half of 2026
Published on 08/13/2026 at 02:00, 4 hours 14 minutes ago

A New Category Is Emerging in the Premium Residential Market — the 'Presidence'
Published on 08/13/2026 at 01:05, 5 hours 9 minutes ago

Pepperstone Appoints New CTO to Drive AI-Native Proprietary Tech Push
Published on 08/12/2026 at 21:05, 9 hours 9 minutes ago

Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Published on 08/12/2026 at 19:57, 10 hours 17 minutes ago

EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million

Les Echos

Published on 08/11/2026 at 17:45, 1 day 12 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 12 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 12 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 12 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 2 days 12 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE